SignalXSignalX

CAPR CAPRICOR THERAPEUTICS, INC.

Q3 2025 10-Q
Filed: Nov 10, 2025Period ending Sep 30, 2025
Health Care
Pharmaceutical PreparationsSEC EDGAR
CAPRICOR THERAPEUTICS, INC. Overview

CAPRICOR THERAPEUTICS, INC. (CAPR) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Nov 10, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

AI Filing Analysis
Q3 2025 10-Q

Risk Factors

  • • New legal risk: securities class action, derivative claims, and Section 220 Demand initiated by stockholders, increasing litigation costs and management distraction
  • • Updated regulatory risk: heightened focus on clinical trial outcomes and approvals due to dependency for business success
+2 more insights

Get deeper insights on CAPRICOR THERAPEUTICS, INC.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.